Clinical Trials · NCT02754817
A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 611
- Start date
- Apr 2016
- Locations
- 5 sites, 5 countries
- Primary endpoint
- Change in HbA1c (Hemoglobin A1c)